Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 24;34(9):1207-1209.
doi: 10.1515/jpem-2021-0038. Print 2021 Sep 27.

MAN1B1-CDG: novel patients and novel variant

Affiliations
Case Reports

MAN1B1-CDG: novel patients and novel variant

Cigdem Seher Kasapkara et al. J Pediatr Endocrinol Metab. .

Abstract

Objectives: Congenital disorders of glycosylation (CDGs) are a group of genetic disorders due to hypoglycosylation of proteins and lipids. A type I pattern is associated with defects in glycan assembly and transfer (CDG-I; cytosol; and endoplasmic reticulum defects), a type II pattern is seen in processing defects of the Golgi apparatus. MAN1B1-CDG is an autosomal recessive CDG-II due to mutations in the α 1,2-mannosidase gene (MAN1B1), mainly characterized by psychomotor disability, facial dysmorphism, truncal obesity, and hypotonia.

Case presentation: Three patients (two males and one female), with MAN1B1-CDG who had elevated transaminase levels are presented. All patients had presented due to dysmorphic and neurological findings and hypertransaminasemia was remarkable. A type 2 pattern was found on serum transferrin isoelectrofocusing analysis of the presented cases. MAN1B1-CDG was confirmed by genetic analysis.

Conclusions: Although the cause of the increased serum transaminase levels in the present patients is not clear, no evidence for an infection or underlying liver pathology could be identified. In order to know if this is a consistent feature, we suggest measuring serum transaminase levels regularly in MAN1B1-CDG patients.

Keywords: MAN1B1-CDG; congenital disorders of glycosylation; transferring isoelectrofocusing.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Chang, IJ, He, M, Lam, CT. Congenital disorders of glycosylation. Ann Transl Med 2018;6:477. https://doi.org/10.21037/atm.2018.10.45.
    1. Balasubramanian, M, Johnson, DS, DDD Study. MAN1B1-CDG: novel variants with a distinct phenotype and review of literature. Eur J Med Genet 2019;62:109–14. https://doi.org/10.1016/j.ejmg.2018.06.011.
    1. Jaeken, J, Lefeber, DJ, Matthijs, G. Clinical utility gene card for: MAN1B1 defective congenital disorder of glycosylation. Eur J Hum Genet 2016;24. https://doi.org/10.1038/ejhg.2015.248.
    1. Rafiq, MA, Kuss, AW, Puettmann, L, Noor, A, Ramiah, A, Ali, G, et al.. Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. Am J Hum Genet 2011;89:176–82. https://doi.org/10.1016/j.ajhg.2011.06.006.
    1. Gupta, S, Fahiminiya, S, Wang, T, Nunez, LD, Rosenblatt, DS, Gibson, WT, et al.. Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A. Cold Spring Harb Mol Case Stud 2016;2:a000737. https://doi.org/10.1101/mcs.a000737.

Publication types

Supplementary concepts

LinkOut - more resources